Transformative research offering fresh insights and treatment advancements for age-related macular degeneration (AMD), the leading cause of blindness in adults over age 50, will be among the highlights showcased from May 4 – 8 at the Association for Research in Vision and Ophthalmology’s (ARVO) 2025 Annual Meeting in Salt Lake City, Utah. 

Read More